|
|
|
|
|
|
Summary Information (see also Sequences/Alignments below) |
Asymmetric/Biological Unit (3, 8) |
Asymmetric Unit (2, 2)
|
(no "SS Bond" information available for 2IY8) |
(no "Cis Peptide Bond" information available for 2IY8) |
(no "SAP(SNP)/Variant" information available for 2IY8) |
(no "PROSITE Motif" information available for 2IY8) |
(no "Exon" information available for 2IY8) |
Asymmetric/Biological UnitChain A from PDB Type:PROTEIN Length:377 aligned with Q9CP67_PASMU | Q9CP67 from UniProtKB/TrEMBL Length:412 Alignment length:389 412 34 44 54 64 74 84 94 104 114 124 134 144 154 164 174 184 194 204 214 224 234 244 254 264 274 284 294 304 314 324 334 344 354 364 374 384 394 404 | Q9CP67_PASMU 25 SKTITLYLDPASLPALNQLMDFTQNNEDKTHPRIFGLSRFKIPDNIITQYQNIHFVELKDNRPTEALFTILDQYPGNIELDIHLNIAHSVQLIRPILAYRFKHLDRVSIQRLNLYDDGSMEYVDLEKEENKDISAEIKQAEKQLSHYLLTGKIKFDNPTIARYVWQSAFPVKYHFLSTDYFEKAEFLQPLKEYLAENYQKMDWTAYQQLTPEQQAFYLTLVGFNDEVKQSLEVQQAKFIFTGTTTWEGNTDVREYYAQQQLNLLNHFTQAGGDLFIGDHYKIYFKGHPRGGEINDYILNNAKNITNIPANISFEVLMMTGLLPDKVGGVASSLYFSLPKEKISHIIFTSNKQVKSKEDALNNPYVKVMRRLGIIDESQVIFWDSLKQL- - SCOP domains d2iy8a_ A: Alpha-2,3/2,6-sialyltransferase/sialidase SCOP domains CATH domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE Transcript ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 2iy8 A 25 SKTITLYLDPASLPALNQLmDFTQNNEDKTHPRIFGLSRFKIPDNIITQYQNIHFVELKDNRPTEALFTILDQYPGNIELNIHLNIAHSVQLIRPILAYRFKHLDRVSIQQLNLYDDGSmEYVDLEKEENKDISAEIKQAEKQLSHYLLTGKIKFDNPTIARYVWQSAFPVKYHFLSTDYFEKAEFLQPLKEYLAENYQKmDWTAYQQLTPEQQAFYLTLVGFNDEVKQSLEVQQAKFIFTGTTTWEGNTEVREYYAQQQLNLLNHFTQAEGDLFIGDHYKIYFKGHPRGGEINDYILNNAKNITNIPANISFEVLmmTGLLPDKVGGVASSLYFSLPKEKISHIIFT------------NNPYVKVmRRLGIIDESQVIFWDSLKELG 413 34 44 54 64 74 84 94 104 114 124 134 144 154 164 174 184 194 204 214 224| 234 244 254 264 274 284 294 304 314 324 334 |344 354 364 | - -| 394 404 44-MSE 144-MSE 225-MSE 341-MSE 372 385 | 342-MSE 392-MSE
|
Asymmetric/Biological Unit
|
(no "CATH Domain" information available for 2IY8) |
(no "Pfam Domain" information available for 2IY8) |
Asymmetric/Biological Unit(hide GO term definitions)
(no "Gene Ontology" information available for 2IY8)
|
|
|
|
|
|
|